Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 41
Filter
1.
Leukemia ; 29(3): 576-85, 2015 Mar.
Article in English | MEDLINE | ID: mdl-25234168

ABSTRACT

In leukemogenesis, Notch signaling can be up and downregulated in a context-dependent manner. The transcription factor hairy and enhancer of split-1 (Hes1) is well-characterized as a downstream target of Notch signaling. Hes1 encodes a basic helix-loop-helix-type protein, and represses target gene expression. Here, we report that deletion of the Hes1 gene in mice promotes acute myeloid leukemia (AML) development induced by the MLL-AF9 fusion protein. We then found that Hes1 directly bound to the promoter region of the FMS-like tyrosine kinase 3 (FLT3) gene and downregulated the promoter activity. FLT3 was consequently upregulated in MLL-AF9-expressing immortalized and leukemia cells with a Hes1- or RBPJ-null background. MLL-AF9-expressing Hes1-null AML cells showed enhanced proliferation and ERK phosphorylation following FLT3 ligand stimulation. FLT3 inhibition efficiently abrogated proliferation of MLL-AF9-induced Hes1-null AML cells. Furthermore, an agonistic anti-Notch2 antibody induced apoptosis of MLL-AF9-induced AML cells in a Hes1-wild type but not a Hes1-null background. We also accessed two independent databases containing messenger RNA (mRNA) expression profiles and found that the expression level of FLT3 mRNA was negatively correlated with those of HES1 in patient AML samples. These observations demonstrate that Hes1 mediates tumor suppressive roles of Notch signaling in AML development, probably by downregulating FLT3 expression.


Subject(s)
Basic Helix-Loop-Helix Transcription Factors/genetics , Gene Expression Regulation, Leukemic , Homeodomain Proteins/genetics , Leukemia, Myeloid, Acute/genetics , fms-Like Tyrosine Kinase 3/genetics , Animals , Basic Helix-Loop-Helix Transcription Factors/deficiency , Cell Proliferation , Disease Models, Animal , Extracellular Signal-Regulated MAP Kinases/genetics , Extracellular Signal-Regulated MAP Kinases/metabolism , Humans , Immunoglobulin J Recombination Signal Sequence-Binding Protein/deficiency , Immunoglobulin J Recombination Signal Sequence-Binding Protein/genetics , Leukemia, Myeloid, Acute/metabolism , Leukemia, Myeloid, Acute/mortality , Leukemia, Myeloid, Acute/pathology , Mice , Mice, Transgenic , Oncogene Proteins, Fusion/genetics , Oncogene Proteins, Fusion/metabolism , Phosphorylation , Promoter Regions, Genetic , Protein Binding , RNA, Messenger/genetics , RNA, Messenger/metabolism , Receptors, Notch/genetics , Receptors, Notch/metabolism , Signal Transduction , Survival Analysis , Transcription Factor HES-1 , fms-Like Tyrosine Kinase 3/metabolism
2.
Blood Cancer J ; 4: e264, 2014 Dec 12.
Article in English | MEDLINE | ID: mdl-25501021

ABSTRACT

TET2 (Ten Eleven Translocation 2) is a dioxygenase that converts methylcytosine (mC) to hydroxymethylcytosine (hmC). TET2 loss-of-function mutations are highly frequent in subtypes of T-cell lymphoma that harbor follicular helper T (Tfh)-cell-like features, such as angioimmunoblastic T-cell lymphoma (30-83%) or peripheral T-cell lymphoma, not otherwise specified (10-49%), as well as myeloid malignancies. Here, we show that middle-aged Tet2 knockdown (Tet2(gt/gt)) mice exhibit Tfh-like cell overproduction in the spleen compared with control mice. The Tet2 knockdown mice eventually develop T-cell lymphoma with Tfh-like features after a long latency (median 67 weeks). Transcriptome analysis revealed that these lymphoma cells had Tfh-like gene expression patterns when compared with splenic CD4-positive cells of wild-type mice. The lymphoma cells showed lower hmC densities around the transcription start site (TSS) and higher mC densities at the regions of the TSS, gene body and CpG islands. These epigenetic changes, seen in Tet2 insufficiency-triggered lymphoma, possibly contributed to predated outgrowth of Tfh-like cells and subsequent lymphomagenesis. The mouse model described here suggests that TET2 mutations play a major role in the development of T-cell lymphoma with Tfh-like features in humans.


Subject(s)
Cell Transformation, Neoplastic/metabolism , DNA-Binding Proteins/biosynthesis , Lymphoma, Follicular/metabolism , Lymphoma, T-Cell/metabolism , Neoplasms, Experimental/metabolism , Proto-Oncogene Proteins/biosynthesis , T-Lymphocytes, Helper-Inducer/metabolism , Animals , Cell Transformation, Neoplastic/genetics , Cell Transformation, Neoplastic/pathology , DNA-Binding Proteins/genetics , Dioxygenases , Gene Knockdown Techniques , Humans , Lymphoma, Follicular/genetics , Lymphoma, Follicular/pathology , Lymphoma, T-Cell/genetics , Lymphoma, T-Cell/pathology , Mice , Mice, Transgenic , Mutation , Neoplasms, Experimental/genetics , Neoplasms, Experimental/pathology , Proto-Oncogene Proteins/genetics , T-Lymphocytes, Helper-Inducer/pathology
3.
Rhinology ; 52(3): 246-51, 2014 09.
Article in English | MEDLINE | ID: mdl-25271530

ABSTRACT

AIM: To describe the features of chronic sinusitis associated with the use of tumour necrosis factor (TNF) inhibitors. METHODOLOGY: A retrospective review of the medical records between 2003 and 2011 revealed that five patients had developed chronic sinusitis after the start of TNF inhibitor administration and required rhinological evaluation and treatment. RESULTS: The incidence of refractory sinusitis associated with TNF inhibitors was approximately 2%. Of the five patients identified, four patients were medicated with etanercept and one with infliximab. The maxillary sinus was most commonly involved and cultures of the sinus discharge revealed Pseudomonas aeruginosa in three cases. Two patients showed improvement of sinusitis with antibiotic medication, despite the continuous use of TNF inhibitor, while in two other patients, sinusitis was resistant to antibiotic medication. Another patient who had developed recurrence of sinusitis after complete remission of previous chronic sinusitis by endoscopic sinus surgery showed remission only after cessation of TNF inhibitor. CONCLUSION: Chronic sinusitis associated with TNF inhibitors is considered to be a new disease entity, and it will become more common due to the increasing use of TNF inhibitors.


Subject(s)
Antibodies, Monoclonal/adverse effects , Antirheumatic Agents/adverse effects , Immunoglobulin G/adverse effects , Maxillary Sinusitis/etiology , Tumor Necrosis Factor-alpha/antagonists & inhibitors , Adult , Arthritis, Rheumatoid/drug therapy , Chronic Disease , Disease Susceptibility/immunology , Etanercept , Female , Humans , Infliximab , Maxillary Sinusitis/diagnostic imaging , Middle Aged , Radiography , Receptors, Tumor Necrosis Factor , Retrospective Studies , Tumor Necrosis Factor-alpha/immunology
4.
Clin Exp Allergy ; 44(5): 701-12, 2014.
Article in English | MEDLINE | ID: mdl-24931597

ABSTRACT

BACKGROUND: Chronic rhinosinusitis with nasal polyps is generally characterized by local Th2 inflammation and is categorized into two subtypes in Japan: eosinophilic chronic rhinosinusitis (similar to chronic rhinosinusitis with nasal polyps in western countries) and non-eosinophilic chronic rhinosinusitis (characterized by Th1-dominant inflammation). OBJECTIVE: To investigate local IgE production and class switch recombination to IgE in these two subtypes of chronic rhinosinusitis with nasal polyps. METHODS: The identity of IgE-positive cells was determined using double-immunofluorescent staining for IgE and cell-type-specific molecular markers. To investigate the local class switch recombination to IgE and IgE synthesis in the mucosa, we performed real-time polymerase chain reaction to examine the mRNA expression of Th2 cytokines and class-switch-related molecules, including IL-4, IL-5, IL-13, ε germline gene transcripts, IgE mature transcript, IgG mature transcript, RAG1, RAG2 and activation-induced cytidine deaminase in eosinophilic polyps, non-eosinophilic polyps and controls. RESULTS: The concentrations of total IgE and number of IgE-positive cells were significantly higher in the eosinophilic polyps compared with control and non-eosinophilic polyps. IgE-positive cells were predominantly mast cells in eosinophilic polyps and significantly correlated with the number of FcεR1-positive cells in the subepithelial layer. IL-5 and IL-13 mRNA and ε germline gene transcripts expression levels were significantly higher in eosinophilic polyps compared with control and non-eosinophilic polyps. In contrast, the number of plasma cells and the expression of IgG mature transcripts were increased in non-eosinophilic polyps compared with eosinophilic polyps. RAG2 mRNA was significantly increased in both eosinophilic and non-eosinophilic polyps compared with control mucosa. CONCLUSION AND CLINICAL RELEVANCE: The current study suggests local class switching to IgE, production of IgE and IgE localization to the surface of mast cells in eosinophilic chronic rhinosinusitis in the Japanese population. The difference in the IgE-related profiles between eosinophilic chronic rhinosinusitis and non-eosinophilic chronic rhinosinusitis suggests heterogeneity in the pathogenesis of chronic rhinosinusitis with nasal polyps.


Subject(s)
Immunoglobulin Class Switching/genetics , Immunoglobulin E/genetics , Immunoglobulin E/immunology , Nasal Polyps/etiology , Rhinitis/complications , Sinusitis/complications , Adult , Aged , B-Lymphocyte Subsets/immunology , B-Lymphocyte Subsets/metabolism , Chronic Disease , Cytokines/genetics , Cytokines/metabolism , DNA-Binding Proteins/genetics , DNA-Binding Proteins/metabolism , Eosinophils/immunology , Female , Gene Expression Regulation , Homeodomain Proteins/genetics , Homeodomain Proteins/metabolism , Humans , Immunoglobulin Class Switching/immunology , Immunoglobulin E/metabolism , Immunoglobulin G/genetics , Immunoglobulin G/immunology , Inflammation/immunology , Inflammation/metabolism , Leukocyte Count , Male , Middle Aged , Nasal Mucosa/immunology , Nasal Mucosa/metabolism , Nasal Mucosa/pathology , Nasal Polyps/diagnosis , Nuclear Proteins/genetics , Nuclear Proteins/metabolism , Phenotype , Receptors, IgE/genetics , Receptors, IgE/metabolism , Rhinitis/diagnosis , Sinusitis/diagnosis
6.
Gene Ther ; 19(12): 1141-9, 2012 Dec.
Article in English | MEDLINE | ID: mdl-22189415

ABSTRACT

We previously demonstrated that an artificial protein, TAT-FNK, has antiapoptotic effects against cochlear hair cell (HC) damage caused by ototoxic agents when applied systemically. To examine the feasibility of topical protein therapy for inner ear disorders, we investigated whether gelatin sponge soaked with TAT-FNK and placed on the guinea pig round window membrane (RWM) could deliver the protein to the cochlea and attenuate aminoglycoside (AG)-induced cochlear damage in vivo. First, we found that the immunoreactivity of TAT-myc-FNK was distributed throughout the cochlea. The immunoreactivity was observed from 1-24 h after application. When Tat-FNK was applied 1 h before ototoxic insult (a combination of kanamycin sulfate and ethacrynic acid), auditory brainstem response threshold shifts and the extent of HC death were significantly attenuated. When cochlear organotypic cultures prepared from P5 rats were treated with kanamycin, TAT-FNK significantly reduced the extent of caspase-9 activation and HC death. These findings indicate that TAT-FNK topically applied on the RWM can enter the cochlea by diffusion and effectively prevent AG-induced apoptosis of cochlear HCs by suppressing the mitochondrial caspase-9 pathway.


Subject(s)
Aminoglycosides/toxicity , Apoptosis/drug effects , Cochlea/drug effects , Gene Products, tat/pharmacology , Labyrinth Diseases/prevention & control , Protein Serine-Threonine Kinases/pharmacology , Recombinant Fusion Proteins/administration & dosage , Administration, Topical , Animals , Caspase 9/metabolism , Cochlea/metabolism , Ethacrynic Acid/pharmacology , Ethacrynic Acid/toxicity , Evoked Potentials, Auditory, Brain Stem/drug effects , Gene Products, tat/administration & dosage , Guinea Pigs , Hair Cells, Auditory/drug effects , Kanamycin/pharmacology , Labyrinth Diseases/chemically induced , Neuroprotective Agents , Protein Serine-Threonine Kinases/administration & dosage , Rats , Recombinant Fusion Proteins/pharmacology , Round Window, Ear , Tumor Suppressor Proteins
7.
Horm Metab Res ; 41(3): 221-6, 2009 Mar.
Article in English | MEDLINE | ID: mdl-19003725

ABSTRACT

Obstructive sleep apnea syndrome (OSAS) is related to the increased prevalence of cardiovascular disease and metabolic syndrome (MS). A novel adipokine, retinol binding protein-4 (RBP4), was reported to be associated with insulin resistance and the prevalence of type 2 diabetes. To examine whether plasma RBP4 is associated with insulin resistance and MS development in OSAS, we measured plasma RBP4 levels in 181 Japanese men (24 healthy controls and 40 mild, 64 moderate, and 53 severe OSAS) of whom 26 had mild glucose intolerance with HbA1c < or = 6.0%. After a full polysomnography, blood was collected between 06:00 and 07:00 AM. Plasma RBP4 levels in moderate/severe OSAS patients were higher than in control subjects. Plasma RBP4 was not correlated with apnea variables, HOMA-IR, or blood pressure. However, it was positively correlated with visceral fat areas and plasma triglyceride levels. The prevalence of MS was higher in severe OSAS patients than in mild/moderate OSAS and control subjects. Plasma RBP4 was higher in OSAS patients with MS than in those without MS. This study indicates that plasma RBP4 is associated with dyslipidemia, but not with insulin resistance, glucose intolerance, or hypertension in patients with OSAS. Visceral obesity may play key roles in increasing the plasma RBP4 level and MS development in OSAS.


Subject(s)
Diabetes Mellitus, Type 2/blood , Obesity/blood , Retinol-Binding Proteins, Plasma/metabolism , Sleep Apnea, Obstructive/blood , Adiponectin/blood , Adult , Aged , Blood Pressure , Diabetes Mellitus, Type 2/complications , Fatty Acids, Nonesterified/blood , Glucose Clamp Technique , Humans , Insulin Resistance , Male , Metabolic Syndrome/blood , Metabolic Syndrome/physiopathology , Middle Aged , Obesity/complications , Oxygen/blood , Reference Values , Sleep , Sleep Apnea, Obstructive/complications , Sleep Apnea, Obstructive/physiopathology , Triglycerides/blood
9.
J Thromb Haemost ; 4(11): 2433-42, 2006 Nov.
Article in English | MEDLINE | ID: mdl-17059472

ABSTRACT

BACKGROUND: There have been only seven reported cases of glycoprotein (GP) VI deficiency. However, the pathogenesis of this disorder has not been well-elucidated. OBJECTIVES: We characterized a novel patient with GPVI deficiency and used these platelets to investigate the role of GPVI in normal hemostasis. PATIENT: A 31-year-old female with immune thrombocytopenic purpura who had been suffering from mild bleeding diathesis even after recovery from thrombocytopenia. RESULTS AND CONCLUSION: The patient's platelets did not aggregate in response to either convulxin or collagen-related peptide. Immunoblotting revealed complete absence of the GPVI molecule, whereas a significantly reduced but substantial amount of Fc receptor (FcR) gamma-chain was expressed. Platelet stimulation with convulxin did not induce tyrosine-phosphorylation of FcR gamma-chain, indicating a defect in GPVI-mediated signaling. Concerning the underlying pathogenesis, we found normal level of GPVI-mRNA expression, no aberration of the sequence of the entire coding region of GPVI, and presence of degraded GPVI in her plasma. However, no anti-GPVI autoantibody was detected either by the binding assay to GPVI-Fc2 fusion protein or by immunoblotting/immunoprecipitation using the patient's immunoglobulin. We thus consider that either a short-time exposure to anti-GPVI autoantibody or a continuous exposure to low titers of the autoantibody has resulted in persistent GPVI deficiency. Under high shear flow, the patient's platelets could not form large aggregates, although initial platelet attachment was obviously observed. These results suggest that GPVI deficiency in this patient resulted in defective platelet thrombi development, manifesting as bleeding diathesis. Furthermore, our observations indicate that coordination of GPVI with integrin alpha2beta1 is essential for physiological platelet thrombus formation.


Subject(s)
Platelet Membrane Glycoproteins/deficiency , Purpura, Thrombocytopenic, Idiopathic/blood , Receptors, IgG/biosynthesis , Signal Transduction , Adult , Asian People , Crotalid Venoms/pharmacology , Female , Humans , Lectins, C-Type , Platelet Aggregation/drug effects , Platelet Membrane Glycoproteins/analysis , Purpura, Thrombocytopenic, Idiopathic/complications
10.
Leukemia ; 20(11): 1963-6, 2006 Nov.
Article in English | MEDLINE | ID: mdl-17008890

ABSTRACT

Activating mutations in NOTCH1 are found in over 50% of human T-cell lymphoblastic leukemias (T-ALLs). Here, we report the analysis for activating NOTCH1 mutations in a large number of acute myeloid leukemia (AML) primary samples and cell lines. We found activating mutations in NOTCH1 in a single M0 primary AML sample, in three (ML1, ML2 and CTV-1) out of 23 AML cell lines and in the diagnostic (myeloid) and relapsed (T-lymphoid) clones in a patient with lineage switch leukemia. Importantly, the ML1 and ML2 AML cell lines are derived from an AML relapse in a patient initially diagnosed with T-ALL. Overall, these results demonstrate that activating mutations in NOTCH1 are mostly restricted to T-ALL and are rare in AMLs. The presence of NOTCH1 mutations in myeloid and T-lymphoid clones in lineage switch leukemias establishes the common clonal origin of the diagnostic and relapse blast populations and suggests a stem cell origin of NOTCH1 mutations during the molecular pathogenesis of these tumors.


Subject(s)
Cell Lineage/genetics , Gene Expression Regulation, Leukemic , Leukemia, Myeloid/genetics , Leukemia, Myeloid/pathology , Receptor, Notch1/genetics , Acute Disease , Base Sequence , Cell Line, Tumor , Gene Deletion , Hematopoietic Stem Cells/pathology , Hematopoietic Stem Cells/physiology , Humans , Point Mutation , Recurrence , T-Lymphocytes/pathology
11.
J Clin Pathol ; 56(11): 871-2, 2003 Nov.
Article in English | MEDLINE | ID: mdl-14600137

ABSTRACT

A 26 year old pregnant woman with antithrombin III deficiency developed recurrent septicaemia with Serratia marcescens. In spite of the administration of antibiotics, high grade fever persisted. She subsequently manifested lower abdominal pain, and spontaneous abortion occurred. After the abortion, she became completely afebrile. The amnion was turbid, and microscopic examination of the placenta showed haemorrhage and massive infiltration of neutrophils, suggestive of infectious chorioamnionitis. Pulsed field gel electrophoresis showed that isolates from the blood, urine, and vaginal discharge were genetically identical. Intravenous pyelography revealed that she had a bilateral completed double ureter. It was thought that a urinary tract anomaly caused infection with S marcescens, and the pathogen spread to the chorioamnion via the bloodstream. This is the first report of chorioamnionitis caused by S marcescens in a non-immunocompromised host. In addition, these findings indicate that the chorioamnion can serve as a site for persistent infection in normal pregnancies.


Subject(s)
Chorioamnionitis/microbiology , Pregnancy Complications, Infectious/diagnosis , Serratia Infections/diagnosis , Serratia marcescens , Abortion, Spontaneous/microbiology , Adult , Female , Humans , Immunocompetence , Pregnancy , Ureter/abnormalities
12.
Ann Hematol ; 82(1): 53-6, 2003 Jan.
Article in English | MEDLINE | ID: mdl-12574967

ABSTRACT

It is now well recognized that hemophagocytic syndrome (HPS) is occasionally associated with malignant lymphomas. However, its association with Hodgkin's disease has been only rarely reported. We present here a 72-year-old woman manifesting with HPS as the primary and solitary clinical symptom of Hodgkin's disease. She had been suffering from high-grade fever and anemia for more than a month. Based on the findings in bone marrow aspirates, she was diagnosed as having HPS. In spite of extensive surveys including various cultures, serological tests for collagen disease, abdominal and cardiac sonography, chest computed tomography (CT), and renal biopsy, the origin of the fever was not determined. She was treated with steroid pulse therapy and then referred. Radiological studies revealed only mild hepatosplenomegaly and small lymph node swellings around celiac and common hepatic arteries. Reevaluation of the bone marrow specimen revealed the infiltration of small numbers of CD30-, CD15-, and EBER-1-positive large-sized lymphocytes with bizarre nucleus. Under the diagnosis of Hodgkin's disease, she was treated with combination chemotherapy containing pirarubicin, cyclophosphamide, vincristine, and prednisolone. However, it was not effective and she died of rapidly progressive hepatic failure on the 5th day of the chemotherapy. Autopsy was performed, which showed proliferation of lymphoma cells in para-aortic lymph nodes. We believe that diagnostic survey to rule out the underlying lymphoma should be vigorously performed for patients with hemophagocytic syndrome of unknown origin.


Subject(s)
Histiocytosis, Non-Langerhans-Cell/complications , Hodgkin Disease/complications , Aged , Bone Marrow Examination , Cytokines/blood , Fatal Outcome , Female , Fever/etiology , Histiocytosis, Non-Langerhans-Cell/diagnosis , Hodgkin Disease/diagnosis , Hodgkin Disease/drug therapy , Humans , Lymph Nodes/pathology
13.
J Biol Chem ; 276(49): 46276-83, 2001 Dec 07.
Article in English | MEDLINE | ID: mdl-11560919

ABSTRACT

We have purified and identified a 32-kDa protein interacting with the Dbl oncogene homology domain of mSos1(Sos-DH) from rat brains by glutathione S-transferase-Sos-DH affinity chromatography. Peptide sequencing revealed that the protein is identical to a positive regulatory E subunit (V-ATPase E) of a vacuolar H(+)-ATPase, which is responsible for acidification of endosome and alkalinization of intracellular pH. The interaction between V-ATPase E and Sos-DH was confirmed by yeast two-hybrid assay. A coimmunoprecipitation assay demonstrated that a V-ATPase E protein physiologically bound to mSos1, and the protein was colocalized with mSos1 in the cytoplasm, as determined by immunohistochemistry. mSos1 was found in the early endosome fraction together with V-ATPase E and Rac1, suggesting the functional involvement of mSos1/V-ATPase E complexes in the Rac1 activity at endosomes. Overexpression of V-ATPase E in COS cells enhanced the ability of mSos1 to promote the guanine nucleotide exchange activity for Rac1 and stimulated the kinase activity of Jun kinase, a downstream target of Rac1. Thus, the data indicate that V-ATPase E may participate in the regulation of the mSos1-dependent Rac1 signaling pathway involved in growth factor receptor-mediated cell growth control.


Subject(s)
Insect Proteins , SOS1 Protein/metabolism , Signal Transduction , Vacuolar Proton-Translocating ATPases/metabolism , rac1 GTP-Binding Protein/metabolism , 3T3 Cells , Amino Acid Sequence , Animals , COS Cells , Chromatography, Affinity , Endosomes/enzymology , Endosomes/metabolism , Immunohistochemistry , Mice , Molecular Sequence Data , Rats , Two-Hybrid System Techniques , Vacuolar Proton-Translocating ATPases/chemistry , Vacuolar Proton-Translocating ATPases/isolation & purification
15.
Blood ; 96(1): 288-96, 2000 Jul 01.
Article in English | MEDLINE | ID: mdl-10891464

ABSTRACT

The t(8;21) translocation is one of the most frequent chromosomal abnormalities associated with acute myeloid leukemia (AML). In this translocation, the AML1 (CBFA2/PEBP2aB) gene is disrupted and fused to the MTG8 (ETO) gene. The ectopic expression of the resulting AML1-MTG8 fusion gene product in L-G and 32Dcl3 murine myeloid precursor cells stimulates cell proliferation without inducing morphologic terminal differentiation into mature granulocytes in response to granulocyte-colony stimulating factor (G-CSF). This study found that the ectopic expression of AML1-MTG8 elevates the expression of the G-CSF receptor (G-CSFR). Analysis of the promoter region of the G-CSFR gene revealed that up-regulation of G-CSFR expression by AML1-MTG8 does not depend on the AML1-binding sequence, but on the C/EBP (CCAAT/enhancer binding protein) binding site. The results suggest that the overproduction of G-CSFR is at least partly mediated by C/EBPepsilon, whose expression is activated by AML1-MTG8. The ectopic expression of G-CSFR in L-G cells induced cell proliferation in response to G-CSF, but did not inhibit cell differentiation into mature neutrophils. Overexpression of C/EBPepsilon in L-G cells also stimulated G-CSF-dependent cell proliferation. High expression levels of G-CSFR were also found in the leukemic cells of AML patients with t(8;21). Therefore, G-CSF-dependent cell proliferation of myeloid precursor cells may be implicated in leukemogenesis.


Subject(s)
DNA-Binding Proteins/genetics , Nuclear Proteins/genetics , Oncogene Proteins, Fusion/genetics , Oncogene Proteins, Fusion/metabolism , Receptors, Granulocyte Colony-Stimulating Factor/genetics , Transcription Factors/genetics , Transcription Factors/metabolism , Animals , Base Sequence , CCAAT-Enhancer-Binding Proteins , Cell Differentiation/drug effects , Cell Division/drug effects , Cell Line , Core Binding Factor Alpha 2 Subunit , DNA Primers , DNA-Binding Proteins/metabolism , Gene Expression Regulation , Granulocyte Colony-Stimulating Factor/pharmacology , Humans , Leukemia, Myeloid/genetics , Mice , Molecular Sequence Data , Nuclear Proteins/metabolism , Polymerase Chain Reaction , Promoter Regions, Genetic , RUNX1 Translocation Partner 1 Protein , Recombinant Proteins/metabolism , Transcription, Genetic , Transfection , Translocation, Genetic
16.
No Shinkei Geka ; 28(6): 561-7, 2000 Jun.
Article in Japanese | MEDLINE | ID: mdl-10875115

ABSTRACT

We present a case of a spontaneous dissecting aneurysm at the vertebrobasilar artery including the right PICA in a 44-year-old man, who suffered from headache, hiccup and ataxic gait. The arteriograms showed an irregular narrowing and dilatation in the right PICA and in the vertebrobasilar artery, and showed fusiform dilatations in the bilateral middle cerebral arteries. We observed intramural hematoma and true lumen at the right PICA dissecting aneurysm on T1-weighted images on magnetic resonance imaging (1.5T, MRI), and the intimal flap was enhanced on T1-weighted image after intravenous injection of Gd-DTPA. The shape of the intramural hematoma showed a unique "two dumplings on a skewer" appearance, and the intensity of its hematoma in the false lumen decreased in gradient from adventitia to intimal flap on T1-weighted image on MRI. The dissecting aneurysm of the PICA was occluded spontaneously 1 month later, and it caused cerebellar infarction. However, the patient has been left only with the symptom of slight trunkal ataxia. Various shapes of intramural hematomas on MRI have been reported by Kitanaka in association with intracranial vertebrobasilar dissections. We suggest that "two dumplings on a skewer" shape which corresponds to the flow void of the true lumen, accompanied by intramural hematoma and enhanced intimal flap, on contrast-enhanced T1-weighted image, should be regarded as a true "diagnostic sign" of a dissecting aneurysm.


Subject(s)
Aortic Dissection/diagnosis , Intracranial Aneurysm/diagnosis , Magnetic Resonance Imaging , Posterior Cerebral Artery/pathology , Adult , Aortic Dissection/pathology , Humans , Intracranial Aneurysm/pathology , Male , Posterior Cerebral Artery/diagnostic imaging , Tomography, X-Ray Computed
17.
Transplantation ; 69(7): 1501-3, 2000 Apr 15.
Article in English | MEDLINE | ID: mdl-10798778

ABSTRACT

Posttransplant lymphoproliferative disorders in organ allograft recipients are most commonly of B-cell origin and only occasionally of T-cell origin. We present here a case of nasal natural killer cell lymphoma associated with Epstein-Barr virus that occurred in a recipient of a renal transplant 4 years posttransplantation. Immunohistochemically, the lymphoma cells showed CD2-, surface CD3-, cytoplasmic CD3E+, CD56+, CD57-, CD16-, and CD43+ phenotype. Analyses of T-cell receptor beta and gamma genes showed germ line configurations. EBER-1 was detectable in the lymphoma cells. The patient was diagnosed as having natural killer cell lymphoma and was treated with six courses of combination chemotherapy for non-Hodgkin's lymphoma He has been in remission for more than 3 years thereafter. To the best of our knowledge, this is the first report of a posttransplant NK cell lymphoma associated with Epstein-Barr virus.


Subject(s)
Kidney Transplantation , Killer Cells, Natural , Lymphoma, T-Cell/etiology , Nasal Cavity , Nose Neoplasms/etiology , Postoperative Complications , Adult , Antigens, CD/analysis , Humans , Lymphoma, T-Cell/chemistry , Lymphoma, T-Cell/diagnosis , Lymphoma, T-Cell/immunology , Magnetic Resonance Imaging , Male , Nasal Cavity/pathology , Nose Neoplasms/chemistry , Nose Neoplasms/diagnosis , Nose Neoplasms/immunology , RNA, Viral/analysis
18.
J Biol Chem ; 275(18): 13175-8, 2000 May 05.
Article in English | MEDLINE | ID: mdl-10788420

ABSTRACT

Nerve growth factor (NGF) stimulation of pheochromocytoma PC12 cells transiently increased the intracellular concentration of reactive oxygen species (ROS). This increase was blocked by the chemical antioxidant N-acetylcysteine and a flavoprotein inhibitor, diphenylene iodonium. NGF responses of PC12 cells, including neurite outgrowth, tyrosine phosphorylation, and AP-1 activation, was inhibited when ROS production was prevented by N-acetylcysteine and diphenylene iodonium. The expression of dominant negative Rac1N17 blocked induction of both ROS generation and morphological differentiation by NGF. The ROS produced appears to be H(2)O(2), because the introduction of catalase into the cells abolished NGF-induced neurite outgrowth, ROS production, and tyrosine phosphorylation. These results suggest that the ROS, perhaps H(2)O(2), acts as an intracellular signal mediator for NGF-induced neuronal differentiation and that NGF-stimulated ROS production is regulated by Rac1 and a flavoprotein-binding protein similar to the phagocytic NADPH oxidase.


Subject(s)
Nerve Growth Factor/pharmacology , Neurons/cytology , Reactive Oxygen Species/physiology , rac1 GTP-Binding Protein/physiology , Animals , Cell Differentiation/drug effects , Cell Differentiation/physiology , Neurons/drug effects , Neurons/physiology , PC12 Cells , Rats , Signal Transduction/drug effects
19.
Genes Chromosomes Cancer ; 27(3): 229-38, 2000 Mar.
Article in English | MEDLINE | ID: mdl-10679911

ABSTRACT

The reciprocal translocation t(1;3)(p36;q21) is associated with myelodysplastic syndromes (MDSs) and acute myeloid leukemia (AML) characterized by trilineage dysplasia, in particular dysmegakaryocytopoiesis, and a poor prognosis. As yet no molecular genetic analyses of the t(1;3) have been reported. In four patients with t(1;3), all of whom had AML-M4, which evolved from MDS, the breakpoints at 3q21 clustered within a 60-kb region centromeric to the breakpoint of the inv(3)(q21q26), whereas the breakpoints at 1p36 clustered within a 90-kb region at 1p36.3. The presence of novel clusters in both the 3q21 and 1p36 breakpoints (BCRs) suggests a common, underlying molecular mechanism for the development of t(1;3)-positive MDS/AML. The Ribophorin I (RPN1) gene close to the BCR at 3q21 was highly expressed without gross structural changes, whereas the GR6 gene located within the BCR at 3q21 was not expressed. No other highly expressed genes were isolated in a 150-kb region at 3q21. Thus, it is likely that a gene at 1p36.3 is activated by the translocation of the 3q21 region or a gene important for transformation lies on 3q21, outside the 150-kb region. Further characterization of the BCRs at 1p36.3 and 3q21 should provide important insights into the molecular genetic mechanisms involved in the genesis of t(1;3)-positive MDS/AML. Genes Chromosomes Cancer 27:229-238, 2000.


Subject(s)
Chromosomes, Human, Pair 1/genetics , Chromosomes, Human, Pair 3/genetics , Hematologic Neoplasms/genetics , Translocation, Genetic/genetics , Aged , Aged, 80 and over , Chromosome Breakage , Fatal Outcome , Humans , Hybrid Cells , In Situ Hybridization, Fluorescence , Leukemia, Myelomonocytic, Acute/genetics , Male , Membrane Proteins/genetics , Middle Aged , Tumor Cells, Cultured
20.
Leukemia ; 13(9): 1359-66, 1999 Sep.
Article in English | MEDLINE | ID: mdl-10482986

ABSTRACT

A cell line (Kasumi-3) established from acute myeloid leukemia (AML-M0) had unique phenotypes of undifferentiated leukemia cells with expression of both T cell and myeloid antigens. Kasumi-3 cells with t(3;7)(q26;q22) highly expressed a 6 kb transcript of EVI1, which is located on chromosome 3q26. Therefore, we further characterized the chromosomal breakpoint by pulsed-field gel electrophoresis near EVI1. We identified and isolated the chromosomal breakpoint at approximately 80 kb upstream from the 5' end of EVI1. Sequence analysis of the breakpoint revealed that the whole Vbeta region from T cell receptor beta (TCRbeta) at 7q35 was translocated to the upstream of EVI1. A 1.0 kb TCRbeta transcript was expressed in the Kasumi-3 cells, suggesting that TCRbeta rearrangement occurred as Dbeta-Jbeta joining events. Fluorescence in situ hybridization analysis revealed that the inverted chromosome 7q22-q35 segment between TCRbeta and the region proximal to the erythropoietin gene at 7q22 was translocated to the region distal to EVI1 in der(3). Since the telomeric region of chromosome 8 q was also translocated to the inverted chromosome 7q22-q35 segment in der(3), the chromosomal abnormalities of der(3) were defined as being der(3)t(3;7;8)(3pter-3q26::7q35-7q22::8q22 -8qter). It is suggested that a translocated enhancer element in the TCRbeta locus and/or loss of a negative regulatory element near EVI1 might function to enhance the EVI1 expression. Therefore, the enhanced EVI1 expression may contribute to the development of a subset of undifferentiated leukemia.


Subject(s)
Chromosomes, Human, Pair 3 , Chromosomes, Human, Pair 7 , Genes, T-Cell Receptor beta , Leukemia, Myeloid/genetics , Proto-Oncogenes , Translocation, Genetic , Acute Disease , Base Sequence , Cell Differentiation/physiology , Chromosome Mapping , Humans , In Situ Hybridization, Fluorescence , Molecular Sequence Data , RNA, Messenger/biosynthesis , Tumor Cells, Cultured
SELECTION OF CITATIONS
SEARCH DETAIL
...